BATS BZX Real-Time Price
As of 12:12pm ET
| -0.0005 / -0.09%|
The 2 analysts offering 12-month price forecasts for Peregrine Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a +163.62% increase from the last price of 0.57.
The current consensus among 2 polled investment analysts is to Buy stock in Peregrine Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.